Approval · Notice of Compliance 4536 · 1996
ALKERAN: Notice of Compliance 4536
Issued April 15, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4536
- Date
- April 15, 1996
- Company
- Glaxo Wellcome Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antineoplastic (alkylating) agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ALKERAN | 02087286 | Marketed |
Medicinal ingredients
- MELPHALAN HCL 50 MG per VIAL